GSTM1 and Cirrhosis: Recently, a randomized clinical trial (RCT) showed that red blood cell transfusion improved survival in patients with cirrhosis and GIB when s-Hb levels dropped below 7 g/dL (restrictive strategy), probably because of a better control of further bleeding, as restitution of blood volume can increase portal hypertension (19).